Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - REPLIGEN CORP | d862842dex321.htm |
| EX-31.2 - EX-31.2 - REPLIGEN CORP | d862842dex312.htm |
| EX-31.1 - EX-31.1 - REPLIGEN CORP | d862842dex311.htm |
| EX-21.1 - EX-21.1 - REPLIGEN CORP | d862842dex211.htm |
| EX-10.4 - EX-10.4 - REPLIGEN CORP | d862842dex104.htm |
| EX-4.5 - EX-4.5 - REPLIGEN CORP | d862842dex45.htm |
| 10-K - FORM 10-K - REPLIGEN CORP | d862842d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statements (Form S-8 No. 333-224978) pertaining to the 2018 Stock Option and Incentive Plan of Repligen Corporation, |
| (2) | Registration Statements (Form S-8 No. 333-196456) pertaining to the Amended and Restated 2012 Stock Option and Incentive Plan of Repligen Corporation, |
| (3) | Registration Statements (Form S-8 No. 333-157168) pertaining to the Second Amended and Restated 2001 Stock Plan of Repligen Corporation, and |
| (4) | Registration Statement (Form S-3 No. 333-231098) of Repligen Corporation |
of our reports dated February 26, 2020 with respect to the consolidated financial statements of Repligen Corporation and the effectiveness of internal control over financial reporting of Repligen Corporation, included in this Annual Report (Form 10-K) of Repligen Corporation for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 26, 2020